Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease
US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle…
21/12/2021 - 4 minutes
Autoimmune disease
Targeted Drugs for Rare Autoimmune Disease Hit Regulatory Milestones
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
01/12/2021 - 4 minutes
Record Series A for Italian Biotech Funds Autoimmune Therapy
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for…
28/07/2020 - 3 minutes
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their…
03/03/2020 - 8 minutes
FDA Greenlights First Treatment for Rare Autoimmune Eye Disease
An antibody drug developed by the Irish biopharma Horizon Therapeutics has been approved by the…
22/01/2020 - 2 minutes
€48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases
ImCheck Therapeutics has raised a Series B round worth €48M to fund the development of…
04/12/2019 - 3 minutes
Argenx Raises Whopping €502M in Global Offering
The Dutch biotech argenx, which develops antibody drugs to treat autoimmune diseases and cancer, has…
11/11/2019 - 2 minutes
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to…
31/10/2019 - 2 minutes
This Biotech Fights Autoimmune Disease with Rare Immune Cells
We come to the biotech hub of Paris, France, where the biotech Ermium Therapeutics is…
18/10/2019 - 3 minutes
UK Biotech Launches with €30M Series A to Treat Autoimmune Disease
MiroBio has spun out of the University of Oxford with a Series A round of…
07/10/2019 - 2 minutes
Why Communication is Key for Getting Ahead in Biotech
Many biotech founders and executives look to VC investors for advice and inspiration, but the…
18/09/2019 - 11 minutes
HiFiBiO’s €60M Series C to Fund Cancer and Autoimmune Disease Antibody Drugs
The French biotech HiFiBiO has raised €60M in a Series C round to finance the…
29/08/2019 - 2 minutes
